The mandatory inspection for compliance with the rules of good manufacturing practice (GMP) of a pharmaceutical manufacturer wishing to introduce its products into civilian circulation on the Russian market has been formalised since January 1, 2014. However, manufacturers often have questions related to the GMP inspection procedure, and consulting bodies, taking advantage of this situation, often boost the prices for their services in the field of GMP inspection assistance.